Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Canadian Health Industry News.
Press releases published on May 7, 2025

Pramana Strengthens Scientific Leadership with Addition of Dr. Adrian Noriega to Advance Neurodegenerative Pipeline
VANCOUVER, British Columbia, May 07, 2025 (GLOBE NEWSWIRE) -- Pramana Pharmaceuticals, a late-stage preclinical biopharmaceutical company developing a transformative small molecule platform targeting the intersection of metabolism, immunity, and …

Ultrack Systems Inc. (OTC: MJLB) Announces Better Pets U.S. Trademark Class Application for Full-Spectrum Pet Wellness Product Line
CONCORD, Ontario, May 07, 2025 (GLOBE NEWSWIRE) -- Ultrack Systems Inc. (OTC: MJLB), an emerging diversified holding company, is pleased to announce that Better Pets, its recent strategic acquisition target under a signed Memorandum of Understanding (MOU), …

Jack.org Appoints New President and Chief Executive Officer
Photo Caption: Michael Braithwaite joins Jack.org as President and CEO on June 16 TORONTO, May 07, 2025 (GLOBE NEWSWIRE) -- Jack.org is thrilled to announce the appointment of Michael Braithwaite (he/him) as its new President and Chief Executive Officer ( …

Jack.org nomme un nouveau président et directeur général
Légende de la photo : Michael Braithwaite deviendra le nouveau PDG de Jack.org le 16 juin. TORONTO, 07 mai 2025 (GLOBE NEWSWIRE) -- Jack.org est ravi d’annoncer la nomination de Michael Braithwaite (il/lui) au poste de nouveau président et directeur …

Knight Therapeutics Announces Relaunch of ONICIT® in Brazil and Mexico
MONTREAL, May 07, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that has assumed full commercial activities and is relaunching ONICIT® IV (palonosetron) in …

Thérapeutique Knight annonce la relance de ONICIT® au Brésil et au Mexique
MONTRÉAL, 07 mai 2025 (GLOBE NEWSWIRE) -- Thérapeutique Knight inc. (TSX : GUD) (« Knight »), société pharmaceutique spécialisée panaméricaine (hors États-Unis), a annoncé aujourd'hui la prise en charge complète des activités commerciales et la relance de …

Spectral Medical Announces Non-Dilutive Financing of Up to $10 Million with Vantive
• Non-Dilutive Financing • Up to US$10 Million Promissory Note Provided by Vantive • If Fully Drawn, Promissory Note is Expected to Fully Fund Spectral to PMX Commercialization • Company to host Corporate Update Call on May 15, 2025 TORONTO, May 07, …

Optigo Biotherapeutics Wins People’s Choice Award at Eyecelerator and Presents Compelling Preclinical Data on Long-Acting Intravitreal Biologics at the ARVO 2025 Conference
Optigo wins People’s Choice Award at the recent Eyecelerator meeting in Park City for proprietary drug anchoring, potential to transform intravitreal drug delivery Preclinical data demonstrates sustained efficacy and safety for six months or more following …